Nasal Brushing Transcriptomics Reveals Candidate Biomarkers of Glucocorticoid Treatment Response in Allergic Rhinitis
- 18 August 2026
- journal article
- research article
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 16 (10) , 1225-1228
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82371124)
This publication has 9 references indexed in Scilit:
- The epithelial barrier: a Janus-faced regulator in allergic airway diseases from defense to inflammationFrontiers in Allergy, 2025
- The role of mTOR activation in steroid-resistant asthma: insights from particulate matter-induced mouse model and patient studiesInflammation Research, 2025
- Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapyAllergy, 2024
- Role of Respiratory Epithelial Cells in Allergic DiseasesCells, 2022
- Novel regulators of airway epithelial barrier function during inflammation: potential targets for drug repurposingExpert Opinion on Therapeutic Targets, 2022
- The Tubulin Code and Tubulin-Modifying Enzymes in Autophagy and CancerCancers, 2021
- Allergic rhinitisNature Reviews Disease Primers, 2020
- Autophagic degradation of KAT2A/GCN5 promotes directional migration of vascular smooth muscle cells by reducing TUBA/α-tubulin acetylationAutophagy, 2019
- TRIM37 deficiency induces autophagy through deregulating the MTORC1-TFEB axisAutophagy, 2018